BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 10462624)

  • 1. Multidrug resistance in human tumors--molecular diagnosis and clinical significance.
    Ramachandran C; Melnick SJ
    Mol Diagn; 1999 Jun; 4(2):81-94. PubMed ID: 10462624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug resistance in renal tumors of childhood.
    Ramachandran C
    Curr Pharm Biotechnol; 2007 Apr; 8(2):99-104. PubMed ID: 17430158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Not only P-glycoprotein: Amplification of the ABCB1-containing chromosome region 7q21 confers multidrug resistance upon cancer cells by coordinated overexpression of an assortment of resistance-related proteins.
    Genovese I; Ilari A; Assaraf YG; Fazi F; Colotti G
    Drug Resist Updat; 2017 May; 32():23-46. PubMed ID: 29145976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multidrug resistance: molecular mechanisms and clinical relevance.
    Ling V
    Cancer Chemother Pharmacol; 1997; 40 Suppl():S3-8. PubMed ID: 9272126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversal of multidrug resistance by transduction of cytokine genes into human colon carcinoma cells.
    Stein U; Walther W; Shoemaker RH
    J Natl Cancer Inst; 1996 Oct; 88(19):1383-92. PubMed ID: 8827016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNA expression of breast cancer resistance protein, lung resistance-related protein, multidrug resistance-associated proteins 1 and 2, and multidrug resistance gene 1 in breast cancer: correlation with chemotherapeutic response.
    Burger H; Foekens JA; Look MP; Meijer-van Gelder ME; Klijn JG; Wiemer EA; Stoter G; Nooter K
    Clin Cancer Res; 2003 Feb; 9(2):827-36. PubMed ID: 12576456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical reversal of drug resistance.
    Goldstein LJ
    Curr Probl Cancer; 1995; 19(2):65-124. PubMed ID: 7600845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemoresistance in non-small-cell lung cancer: can multidrug resistance markers predict the response of xenograft lung cancer models to chemotherapy?
    Merk J; Rolff J; Dorn C; Leschber G; Fichtner I
    Eur J Cardiothorac Surg; 2011 Jul; 40(1):e29-33. PubMed ID: 21420313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atypical multidrug resistance: breast cancer resistance protein messenger RNA expression in mitoxantrone-selected cell lines.
    Ross DD; Yang W; Abruzzo LV; Dalton WS; Schneider E; Lage H; Dietel M; Greenberger L; Cole SP; Doyle LA
    J Natl Cancer Inst; 1999 Mar; 91(5):429-33. PubMed ID: 10070941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deletions of multidrug resistance gene loci in breast cancer leads to the down-regulation of its expression and predict tumor response to neoadjuvant chemotherapy.
    Litviakov NV; Cherdyntseva NV; Tsyganov MM; Slonimskaya EM; Ibragimova MK; Kazantseva PV; Kzhyshkowska J; Choinzonov EL
    Oncotarget; 2016 Feb; 7(7):7829-41. PubMed ID: 26799285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular mechanisms of multidrug resistance in cancer chemotherapy.
    Nooter K; Stoter G
    Pathol Res Pract; 1996 Jul; 192(7):768-80. PubMed ID: 8880878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. P-glycoproteins in pathology: the multidrug resistance gene family in humans.
    Weinstein RS; Kuszak JR; Kluskens LF; Coon JS
    Hum Pathol; 1990 Jan; 21(1):34-48. PubMed ID: 1967244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative evaluation by semiquantitative reverse transcriptase polymerase chain reaction of MDR1, MRP and GSTp gene expression in breast carcinomas.
    Lacave R; Coulet F; Ricci S; Touboul E; Flahault A; Rateau JG; Cesari D; Lefranc JP; Bernaudin JF
    Br J Cancer; 1998 Mar; 77(5):694-702. PubMed ID: 9514046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of multidrug resistance 1 (MDR1), multidrug resistance-related protein 1 (MRP1), lung resistance protein (LRP), and breast cancer resistance protein (BCRP) genes and clinical outcome in childhood acute lymphoblastic leukemia.
    Kourti M; Vavatsi N; Gombakis N; Sidi V; Tzimagiorgis G; Papageorgiou T; Koliouskas D; Athanassiadou F
    Int J Hematol; 2007 Aug; 86(2):166-73. PubMed ID: 17875533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug resistance-associated marker Lrp for prediction of response to chemotherapy and prognoses in advanced ovarian carcinoma.
    Izquierdo MA; van der Zee AG; Vermorken JB; van der Valk P; Beliƫn JA; Giaccone G; Scheffer GL; Flens MJ; Pinedo HM; Kenemans P
    J Natl Cancer Inst; 1995 Aug; 87(16):1230-7. PubMed ID: 7563169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative immunocytochemical assays of P-glycoprotein in breast carcinomas: correlation to messenger RNA expression and to immunohistochemical prognostic indicators.
    Charpin C; Vielh P; Duffaud F; Devictor B; Andrac L; Lavaut MN; Allasia C; Horschowski N; Piana L
    J Natl Cancer Inst; 1994 Oct; 86(20):1539-45. PubMed ID: 7932810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversal of P-glycoprotein-mediated multidrug resistance by CD44 antibody-targeted nanocomplexes for short hairpin RNA-encoding plasmid DNA delivery.
    Gu J; Fang X; Hao J; Sha X
    Biomaterials; 2015 Mar; 45():99-114. PubMed ID: 25662500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological strategies for overcoming multidrug resistance.
    Nobili S; Landini I; Giglioni B; Mini E
    Curr Drug Targets; 2006 Jul; 7(7):861-79. PubMed ID: 16842217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of multidrug resistance in oncology and hematology].
    Petrini M; Galimberti S
    Tumori; 1997; 83(5 Suppl):S17-20. PubMed ID: 9446254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcriptional regulation of multidrug resistance in breast cancer.
    Glazer RI; Rohlff C
    Breast Cancer Res Treat; 1994; 31(2-3):263-71. PubMed ID: 7881104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.